 您的位置：对照品 > 标准品 > 欧洲药典标准品 > |
|
|
|
| 产品基本信息 |
|
| 产品编号：M199803 |
| 产品名称：MDV 3100-d6 (Enzalutamide-d6) |
| 产品CAS：1443331-94-9 |
| 规格含量：2.5mg |
| 产品价格：面议 |
| 联系我们: |
 |
|
 |
|
|
| 产品详细介绍 |
| 标准品编号: |
M199803 |
| 名称: |
MDV 3100-d6 (Enzalutamide-d6) |
| 别名: |
4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide-d6; MDV3100-d6; |
| CAS号: |
1443331-94-9 |
| 参考CAS号: |
类似: 915087-33-1 |
| 分子式: |
C₂₁H₁₀D₆F₄N₄O₂S |
| 分子量: |
470.47 |
| 种类: |
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: |
Isotope labelled MDV 3100 is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. MDV 3100 has also been shown to induce tumor cell apoptosis, and has no agonist activity. MDV 3100 is a candidate for the treatment of castration-resistant prostate cancer. |
| 参考文献 |
|
|
|
|
|
|
